Literature DB >> 33740030

Development and validation of a predictive model for critical illness in adult patients requiring hospitalization for COVID-19.

Neha Paranjape1, Lauren L Staples2, Christina Y Stradwick2, Herman Gene Ray2, Ian J Saldanha3,4.   

Abstract

BACKGROUND: Identifying factors that can predict severe disease in patients needing hospitalization for COVID-19 is crucial for early recognition of patients at greatest risk.
OBJECTIVE: (1) Identify factors predicting intensive care unit (ICU) transfer and (2) develop a simple calculator for clinicians managing patients hospitalized with COVID-19.
METHODS: A total of 2,685 patients with laboratory-confirmed COVID-19 admitted to a large metropolitan health system in Georgia, USA between March and July 2020 were included in the study. Seventy-five percent of patients were included in the training dataset (admitted March 1 to July 10). Through multivariable logistic regression, we developed a prediction model (probability score) for ICU transfer. Then, we validated the model by estimating its performance accuracy (area under the curve [AUC]) using data from the remaining 25% of patients (admitted July 11 to July 31).
RESULTS: We included 2,014 and 671 patients in the training and validation datasets, respectively. Diabetes mellitus, coronary artery disease, chronic kidney disease, serum C-reactive protein, and serum lactate dehydrogenase were identified as significant risk factors for ICU transfer, and a prediction model was developed. The AUC was 0.752 for the training dataset and 0.769 for the validation dataset. We developed a free, web-based calculator to facilitate use of the prediction model (https://icucovid19.shinyapps.io/ICUCOVID19/).
CONCLUSION: Our validated, simple, and accessible prediction model and web-based calculator for ICU transfer may be useful in assisting healthcare providers in identifying hospitalized patients with COVID-19 who are at high risk for clinical deterioration. Triage of such patients for early aggressive treatment can impact clinical outcomes for this potentially deadly disease.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33740030      PMCID: PMC7978341          DOI: 10.1371/journal.pone.0248891

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  13 in total

1.  Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.

Authors:  Gary S Collins; Johannes B Reitsma; Douglas G Altman; Karel G M Moons
Journal:  Ann Intern Med       Date:  2015-01-06       Impact factor: 25.391

2.  A Novel Scoring System for Prediction of Disease Severity in COVID-19.

Authors:  Chi Zhang; Ling Qin; Kang Li; Qi Wang; Yan Zhao; Bin Xu; Lianchun Liang; Yanchao Dai; Yingmei Feng; Jianping Sun; Xuemei Li; Zhongjie Hu; Haiping Xiang; Tao Dong; Ronghua Jin; Yonghong Zhang
Journal:  Front Cell Infect Microbiol       Date:  2020-06-05       Impact factor: 5.293

3.  Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.

Authors:  Christopher M Petrilli; Simon A Jones; Jie Yang; Harish Rajagopalan; Luke O'Donnell; Yelena Chernyak; Katie A Tobin; Robert J Cerfolio; Fritz Francois; Leora I Horwitz
Journal:  BMJ       Date:  2020-05-22

Review 4.  Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis.

Authors:  Brandon Michael Henry; Gaurav Aggarwal; Johnny Wong; Stefanie Benoit; Jens Vikse; Mario Plebani; Giuseppe Lippi
Journal:  Am J Emerg Med       Date:  2020-05-27       Impact factor: 2.469

5.  Prediction model and risk scores of ICU admission and mortality in COVID-19.

Authors:  Zirun Zhao; Anne Chen; Wei Hou; James M Graham; Haifang Li; Paul S Richman; Henry C Thode; Adam J Singer; Tim Q Duong
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

6.  Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy.

Authors:  Fabio Ciceri; Antonella Castagna; Patrizia Rovere-Querini; Francesco De Cobelli; Annalisa Ruggeri; Laura Galli; Caterina Conte; Rebecca De Lorenzo; Andrea Poli; Alberto Ambrosio; Carlo Signorelli; Eleonora Bossi; Maria Fazio; Cristina Tresoldi; Sergio Colombo; Giacomo Monti; Efgeny Fominskiy; Stefano Franchini; Marzia Spessot; Carlo Martinenghi; Michele Carlucci; Luigi Beretta; Anna Maria Scandroglio; Massimo Clementi; Massimo Locatelli; Moreno Tresoldi; Paolo Scarpellini; Gianvito Martino; Emanuele Bosi; Lorenzo Dagna; Adriano Lazzarin; Giovanni Landoni; Alberto Zangrillo
Journal:  Clin Immunol       Date:  2020-06-12       Impact factor: 3.969

7.  Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis.

Authors:  Mária Földi; Nelli Farkas; Szabolcs Kiss; Noémi Zádori; Szilárd Váncsa; Lajos Szakó; Fanni Dembrovszky; Margit Solymár; Eszter Bartalis; Zsolt Szakács; Petra Hartmann; Gabriella Pár; Bálint Erőss; Zsolt Molnár; Péter Hegyi; Andrea Szentesi
Journal:  Obes Rev       Date:  2020-07-19       Impact factor: 10.867

8.  C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection.

Authors:  Bikash R Sahu; Raj Kishor Kampa; Archana Padhi; Aditya K Panda
Journal:  Clin Chim Acta       Date:  2020-06-05       Impact factor: 3.786

9.  Comparing Rapid Scoring Systems in Mortality Prediction of Critically Ill Patients With Novel Coronavirus Disease.

Authors:  Hai Hu; Ni Yao; Yanru Qiu
Journal:  Acad Emerg Med       Date:  2020-05-21       Impact factor: 5.221

10.  Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts.

Authors:  Victor M Castro; Thomas H McCoy; Roy H Perlis
Journal:  JAMA Netw Open       Date:  2020-10-01
View more
  2 in total

1.  A 12-hospital prospective evaluation of a clinical decision support prognostic algorithm based on logistic regression as a form of machine learning to facilitate decision making for patients with suspected COVID-19.

Authors:  Monica I Lupei; Danni Li; Nicholas E Ingraham; Karyn D Baum; Bradley Benson; Michael Puskarich; David Milbrandt; Genevieve B Melton; Daren Scheppmann; Michael G Usher; Christopher J Tignanelli
Journal:  PLoS One       Date:  2022-01-05       Impact factor: 3.752

2.  Dealing with COVID-19 Epidemic in Italy: Responses from Regional Organizational Models during the First Phase of the Epidemic.

Authors:  Maria Lucia Specchia; Andrea Di Pilla; Martina Sapienza; Maria Teresa Riccardi; Americo Cicchetti; Gianfranco Damiani; Instant Report Group
Journal:  Int J Environ Res Public Health       Date:  2021-05-09       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.